ArticleFrontiers in oncology2025

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review.

Junjun Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.